AppLovin Beats Earnings, but the SEC Investigation Is the Real Story Investors Should Be Watching

AppLovin (APP) delivered strong Q3 results, with revenue up 68% to $1.41 billion and adjusted EBITDA increasing 90%, both surpassing analyst estimates, largely driven by its AI-powered Axon adtech platform following the divestiture of its mobile gaming business. Despite this robust performance and optimistic Q4 guidance, the stock's upside was constrained by an ongoing SEC probe into allegations that its data collection practices, particularly via Axon, impermissibly utilize user IDs from other apps for targeted advertising. This investigation presents a material risk to AppLovin's future valuations and the growth trajectory of its core adtech platform, despite strong analyst projections for continued expansion.

Analysis

AppLovin (APP) reported robust third-quarter earnings, with revenue surging 68% year-over-year to $1.41 billion and adjusted EBITDA jumping 90% to $1.16 billion, both exceeding analyst expectations. This strong performance, which excludes its divested mobile gaming business, was primarily driven by its AI-powered Axon ad discovery platform. The company also provided optimistic Q4 guidance, projecting 12-14% sequential revenue growth and adjusted EBITDA increases, surpassing consensus estimates.

Despite these strong financial results and positive outlook, the stock's post-earnings gains were notably capped by an ongoing Securities and Exchange Commission (SEC) probe. This investigation centers on allegations that AppLovin's data collection practices, particularly through its Axon platform, impermissibly utilize user IDs from other applications for targeted advertising. The company's 10-Q filing acknowledges potential adverse impacts on its business and financial condition if these claims are successful, and even defense costs could divert critical management resources.

This regulatory uncertainty significantly overshadows AppLovin's otherwise strong growth trajectory, with analysts projecting a 27% revenue CAGR and 42% adjusted EBITDA CAGR through 2027. Insider selling, notably over four times the volume in the past three months, indicates a cautious sentiment among company executives. While current valuations of 28x next year's revenue and 34x adjusted EBITDA appear reasonable, they are highly contingent on the unhindered expansion of the Axon platform, which is now under intense regulatory scrutiny.

Key Decisions for Investors

• Closely monitor the SEC probe's progress and potential outcomes, as regulatory clarity is crucial for AppLovin's future valuation and growth.
• Consider the implications of recent insider selling, which suggests a cautious executive sentiment despite strong financial performance.
• Evaluate the stock's risk-reward profile, weighing its robust adtech fundamentals against the significant regulatory overhang before making substantial investment decisions.